Amplia Therapeutics
(OTC) INNMF
Amplia Therapeutics Financials at a Glance
Market Cap
$41.07M
Revenue (TTM)
A$3.78M
Net Income (TTM)
-A$14.11M
EPS (TTM)
-$0.01
P/E Ratio
-7.27
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.08
Volume
64
Open
$0.08
Price
$0.08
Volume
64
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.09
52-Week Range
$0.05 - $0.27
Estimated Earnings Date
Nov 27, 2026
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.08
Volume
64
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.09
52-Week Range
$0.05 - $0.27
Estimated Earnings Date
Nov 27, 2026
INNMF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amplia Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Christopher J. Burns, PhD
Website
www.ampliatx.comHeadquarters
Melbourne, VIC 3000, AU
INNMF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-25%
Return on Capital
-33%
Return on Assets
-19%
Earnings Yield
-13.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$41.07M
Shares Outstanding
513.31M
Volume
64
Avg. Volume
35.04K
Financials (TTM)
Gross Profit
-A$92.31K
Operating Income
-A$13.21M
EBITDA
-A$13.11M
Operating Cash Flow
-A$8.75M
Capital Expenditure
-A$33.37K
Free Cash Flow
-A$8.78M
Cash & ST Invst.
A$27.91M
Total Debt
A$341.75K
Amplia Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$0.00
-100.0%
Gross Profit
-A$55.95K
-103.3%
Gross Margin
0.00%
N/A
Market Cap
$41.07M
N/A
Market Cap/Employee
$41.07M
N/A
Employees
1
N/A
Net Income
-A$3.54M
-4.8%
EBITDA
-A$6.13M
-82.1%
Quarterly Fundamentals
Total Cash
A$27.91M
+724.3%
Total Debt
A$341.75K
-78.5%
Accounts Receivable
A$4.79M
+50.7%
Inventory
A$0.00
N/A
Long Term Debt
A$252.34K
+1716.3%
Short Term Debt
A$89.42K
-94.3%
Return on Assets
-18.60%
N/A
Return on Invested Capital
-33.14%
N/A
Free Cash Flow
-A$1.10M
+31.0%
Operating Cash Flow
-A$1.09M
+31.3%